One of the necessary components in the understanding and treatment of cancer is the knowledge of how cells reproduce themselves in a highly controlled and regulated manner. Within the past few years, tremendous advancements have been made in our understanding of how the eukaryotic cell cycle is regulated. In species as diverse as yeast and man, proteins with remarkable conservation in both structure and function have been identified. The subject of this proposal is one of these key cell-cycle regulators, a serine/threonine protein kinase referred to as p34cdc2 are regulated throughout the cell cycle. p34cdc2 as well as several of its regulators have been overproduced in insect cells using a baculoviral expression system. These regulators include the wee1+ gene product (a negative regulator of mitosis) and cyclins A and B (positive regulators of mitosis). We have made the novel observation that p34cdc2 becomes phosphorylated on tyrosine when co-produced with the wee1+ gene product in insect cells. Further, the tyrosine phosphorylation of p34cdc2 increases dramatically when cyclin is also present. These results suggest a role for both p107wee1 and cyclin in the regulation of p34cdc2 by tyrosine phosphorylation. This proposal utilizes recently developed techniques and unique reagents to analyze in detail how the phosphorylation and kinase activity of p34cdc2 is regulated by p107wee1 and the cyclins. This information is expected to contribute significantly to our understanding of cell cycle control. In addition, important information regarding both the mechanisms that operate to control cell growth and the identification of pathways that are disrupted during oncogenic transformation may be obtained.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
7R01GM047017-05
Application #
2184495
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1992-02-01
Project End
1995-01-31
Budget Start
1994-08-01
Budget End
1995-01-31
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Washington University
Department
Physiology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Origanti, S; Cai, S-r; Munir, A Z et al. (2013) Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells. Oncogene 32:577-88
Huh, Jiwon; Piwnica-Worms, Helen (2013) CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol Cell Biol 33:213-26
Honaker, Y; Piwnica-Worms, H (2010) Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction. Oncogene 29:3324-34
Leung-Pineda, Van; Huh, Jiwon; Piwnica-Worms, Helen (2009) DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. Cancer Res 69:2630-7
Kang, Tiebang; Wei, Yongkun; Honaker, Yuchi et al. (2008) GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell 13:36-47
Tarakanova, Vera L; Leung-Pineda, Van; Hwang, Seungmin et al. (2007) Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 1:275-86
Brooks, William S; Banerjee, Sami; Crawford, David F (2007) G2E3 is a nucleo-cytoplasmic shuttling protein with DNA damage responsive localization. Exp Cell Res 313:665-76
Rothblum-Oviatt, C J; Ryan, C E; Piwnica-Worms, H (2001) 14-3-3 binding regulates catalytic activity of human Wee1 kinase. Cell Growth Differ 12:581-9
Thorson, J A; Yu, L W; Hsu, A L et al. (1998) 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol Cell Biol 18:5229-38
Peng, C Y; Graves, P R; Ogg, S et al. (1998) C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ 9:197-208

Showing the most recent 10 out of 17 publications